Business Description
Chengdu Okay Pharmaceutical Co Ltd
ISIN : CNE100005MD3
Compare
Compare
Traded in other countries / regions
833230.China IPO Date
2022-12-09Description
Chengdu Okay Pharmaceutical Co Ltd engages in research and development, production, and sales of plant extracts. It specializes in natural vitamin P products, including large-scale professional planting to extraction, purification, synthesis, and application. Its product series include Citrus Extract Series, Sophorae Japonica Series, and Miscellaneous Extract series.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.31 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.85 | |||||
| Interest Coverage | 121.34 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 13.93 | |||||
| Beneish M-Score | -0.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.9 | |||||
| 3-Year EBITDA Growth Rate | -18.3 | |||||
| 3-Year EPS without NRI Growth Rate | -14.9 | |||||
| 3-Year Book Growth Rate | 39 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.61 | |||||
| 9-Day RSI | 69.06 | |||||
| 14-Day RSI | 66.68 | |||||
| 6-1 Month Momentum % | 1.13 | |||||
| 12-1 Month Momentum % | 6.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.54 | |||||
| Quick Ratio | 4.27 | |||||
| Cash Ratio | 1.37 | |||||
| Days Inventory | 121.45 | |||||
| Days Sales Outstanding | 79.03 | |||||
| Days Payable | 20.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.56 | |||||
| Dividend Payout Ratio | 0.76 | |||||
| Forward Dividend Yield % | 1.56 | |||||
| 5-Year Yield-on-Cost % | 1.56 | |||||
| 3-Year Average Share Buyback Ratio | -9.2 | |||||
| Shareholder Yield % | 3.4 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 17.75 | |||||
| Operating Margin % | 8.49 | |||||
| Net Margin % | 7.71 | |||||
| FCF Margin % | -53.24 | |||||
| ROE % | 5.16 | |||||
| ROA % | 4.67 | |||||
| ROIC % | 6.53 | |||||
| ROC (Joel Greenblatt) % | 8.7 | |||||
| ROCE % | 5.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 50.66 | |||||
| PE Ratio without NRI | 50.27 | |||||
| Shiller PE Ratio | 34.47 | |||||
| PEG Ratio | 5.78 | |||||
| PS Ratio | 3.88 | |||||
| PB Ratio | 2.54 | |||||
| Price-to-Tangible-Book | 2.61 | |||||
| EV-to-EBIT | 33.06 | |||||
| EV-to-EBITDA | 33.06 | |||||
| EV-to-Revenue | 2.96 | |||||
| EV-to-FCF | -5.55 | |||||
| Price-to-Projected-FCF | 8.18 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.21 | |||||
| Price-to-Graham-Number | 2.41 | |||||
| Price-to-Net-Current-Asset-Value | 5.49 | |||||
| Price-to-Net-Cash | 146.33 | |||||
| Earnings Yield (Greenblatt) % | 3.02 | |||||
| FCF Yield % | -14.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chengdu Okay Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 262.894 | ||
| EPS (TTM) (Â¥) | 0.26 | ||
| Beta | -2.82 | ||
| Volatility % | 68.9 | ||
| 14-Day RSI | 66.68 | ||
| 14-Day ATR (Â¥) | 0.996522 | ||
| 20-Day SMA (Â¥) | 10.404 | ||
| 12-1 Month Momentum % | 6.06 | ||
| 52-Week Range (Â¥) | 8.21 - 17.3 | ||
| Shares Outstanding (Mil) | 75.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chengdu Okay Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chengdu Okay Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chengdu Okay Pharmaceutical Co Ltd Frequently Asked Questions
What is Chengdu Okay Pharmaceutical Co Ltd(BJSE:833230)'s stock price today?
The current price of BJSE:833230 is ¥13.17. The 52 week high of BJSE:833230 is ¥17.30 and 52 week low is ¥8.21.
When is next earnings date of Chengdu Okay Pharmaceutical Co Ltd(BJSE:833230)?
The next earnings date of Chengdu Okay Pharmaceutical Co Ltd(BJSE:833230) is .
Does Chengdu Okay Pharmaceutical Co Ltd(BJSE:833230) pay dividends? If so, how much?
The Dividend Yield %  of Chengdu Okay Pharmaceutical Co Ltd(BJSE:833230) is 1.56% (As of Today), Highest Dividend Payout Ratio of Chengdu Okay Pharmaceutical Co Ltd(BJSE:833230) was 0.83. The lowest was 0.76. And the median was 0.83. The  Forward Dividend Yield % of Chengdu Okay Pharmaceutical Co Ltd(BJSE:833230) is 1.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers